Q&A: Merck Research Head Mulls Second-Gen Sequencing, Cloud Computing, and Pharma-IT Standards

BioInform spoke with Martin Leach, executive director of basic research and biomarker information technology for Merck Research Labs, about future directions of pharma information technology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.